Role of obesity-induced inflammation in the development of insulin resistance and type 2 diabetes: history of the research and remaining questions

키워드

참고문헌 (71)

1. 김보연, "Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status", Diabetes and Metabolism Journal, 43(4), pp.487~494 (2019), 대한당뇨병학회[DOI]
2. Diabetes Prevention Program Research Group, "10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study", Lancet, 374, pp.1677~1686 (2009)
3. Smith SR, "Orlistat 60 mg reduces visceral adipose tissue : a 24-week randomized, placebo-controlled, multicenter trial", Obesity(Silver Spring), 19, pp.1796~1803 (2011)
4. Perkovic V, "Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy", N Engl J Med, 380, pp.2295~2306 (2019)
5. Shin NR, "An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice", Gut, 63, pp.727~735 (2014)
6. Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha : direct role in obesity-linked insulin resistance", Science, 259, pp.87~91 (1993)
7. Pradhan AD, "C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus", JAMA, 286, pp.327~334 (2001)
8. Yuan M, "Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta", Science, 293, pp.1673~1677 (2001)
9. Pekala P, "Studies of insulin resistance in adipocytes induced by macrophage mediator", J Exp Med, 157, pp.1360~1365 (1983)
10. Uysal KT, "Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function", Nature, 389, pp.610~614 (1997)
11. Uysal KT, "Functional analysis of tumor necrosis factor(TNF)receptors in TNFalpha-mediated insulin resistance in genetic obesity", Endocrinology, 139, pp.4832~4838 (1998)
12. Hotamisligil GS, "IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance", Science, 271, pp.665~668 (1996)
13. Aguirre V, "Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action", J Biol Chem, 277, pp.1531~1537 (2002)
14. Werner ED, "Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302", J Biol Chem, 279, pp.35298~35305 (2004)
15. Stephens JM, "Tumor necrosis factoralpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1and GLUT4 expression without a loss of insulin receptormediated signal transduction", J Biol Chem, 272, pp.971~976 (1997)
16. Hotamisligil GS, "Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance", J Clin Invest, 95, pp.2409~2415 (1995)
17. Xu H, "Altered tumor necrosis factor-alpha(TNF-alpha)processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity", Diabetes, 51, pp.1876~1883 (2002)
18. Donath MY, "Targeting inflammation in the treatment of type 2 diabetes : time to start", Nat Rev Drug Discov, 13, pp.465~476 (2014)
19. Sen R, "Multiple nuclear factors interact with the immunoglobulin enhancer sequences", Cell, 46, pp.705~716 (1986)
20. Ghosh S, "Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B", Nature, 344, pp.678~682 (1990)
21. DiDonato JA, "A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB", Nature, 388, pp.548~554 (1997)
22. Lemaitre B, "The dorsoventral regulatory gene cassette spätzle", Toll, Cell, pp.1996, 86[DOI]
23. Medzhitov R, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity", Nature, 388, pp.394~397 (1997)
24. Poltorak A, "Defective LPS signaling in C3H", HeJ and C57BL, Science, pp.1998, 282[DOI]
25. Ridker PM, "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men", N Engl J Med, 336, pp.973~979 (1997)
26. Goldfine AB, "Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes", Clin Transl Sci, 1, pp.36~43 (2008)
27. Goldfine AB, "Salicylate(salsalate)in patients with type 2diabetes : a randomized trial", Ann Intern Med, 159, pp.1~12 (2013)
28. Goldfine AB, "The effects of salsalate on glycemic control in patients with type 2 diabetes : a randomized trial", Ann Intern Med, 152, pp.346~357 (2010)
29. Cai D, "Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB", Nat Med, 11, pp.183~190 (2005)
30. Arkan MC, "IKK-beta links inflammation to obesity-induced insulin resistance", Nat Med, 11, pp.191~198 (2005)
31. Cai D, "IKKbeta", NF-kappaB activation causes severe muscle wasting in mice, 2004, pp.119, 285~298
32. Kwon H, "Adipocyte-specific IKKβ signaling suppresses adipose tissue inflammation through an IL-13-dependent paracrine feedback pathway", Cell Rep, 9, pp.1574~1583 (2014)
33. Park SH, "IKKβ Is Essential for Adipocyte Survival and Adaptive Adipose Remodeling in Obesity", Diabetes, 65, pp.1616~1629 (2016)
34. Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue", J Clin Invest, 112, pp.1796~1808 (2003)
35. Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance", J Clin Invest, 112, pp.1821~1830 (2003)
36. Osborn O, "The cellular and signaling networks linking the immune system and metabolism in disease", Nat Med, 18, pp.363~374 (2012)
37. Lee BC, "Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance", Biochim Biophys Acta, 1842, pp.446~462 (2014)
38. Lumeng CN, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization", J Clin Invest, 117, pp.175~184 (2007)
39. Gordon S, "Monoc yte and macrophage heterogeneity", Nat Rev Immunol, 5, pp.953~964 (2005)
40. Sic a A, "Macrophage pl asticity and polarization : in vivo veritas", J Clin Invest, 122, pp.787~795 (2012)
41. Xu X, "Obesity activates a program of lysosomaldependent lipid metabolism in adipose tissue macrophages independ ntly of classic activation", Cell Metab, 18, pp.816~830 (2013)
42. Kim MS, "Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone", PLoS One, 8, pp.e82847~ (2013)
43. Camell CD, "Inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing", Nature, 550, pp.119~123 (2017)
44. Cereijo R, "CXCL14, a Brown Adipokine that Mediates BrownFat-to-Macrophage Communication in Thermogenic Adaptation", Cell Metab, 28, pp.750~763 (2018)
45. Wolf Y, "Brown-adipose-tissue macrophages control tissue innervation and homeostatic energ y expenditure", Nat Immunol, 18, pp.665~674 (2017)
46. Tanaka M, "Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis", Nat Commun, 5, pp.4982~ (2014)
47. Spencer M, "Adipose tissue macrophages in insulinresistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation", Am J Physiol Endocrinol Metab, 299, pp.E1016~E1027 (2010)
48. Feuerer M, "Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters", Nat Med, 15, pp.930~939 (2009)
49. Winer S, "Normalization of obesity-associated insulin resistance through immunotherapy", Nat Med, 15, pp.921~929 (2009)
50. Nishimura S, "CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity", Nat Med, 15, pp.914~920 (2009)
51. Liu J, "Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice", Nat Med, 15, pp.940~945 (2009)
52. Stefanovic-Racic M, "Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver", Diabetes, 61, pp.2330~2339 (2012)
53. Talukdar S, "Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase", Nat Med, 18, pp.1407~1412 (2012)
54. Zúñiga LA, "IL-17 regulates adipogenesis, glucose homeostasis, and obesity", J Immunol, 185, pp.6947~6959 (2010)
55. Mehta P, "γδ T cells promote inflammation and insulin resistance during high fat dietinduced obesity in mice", J Leukoc Biol, 97, pp.121~134 (2015)
56. Winer DA, "B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies", Nat Med, 17, pp.610~617 (2011)
57. Lee BC, "Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity", Cell Metab, 23, pp.685~698 (2016)
58. O'Sullivan TE, "Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance", Immunity, 45, pp.428~441 (2016)
59. Nishimura S, "Adipose Natural Regulatory B Cells Negatively Control Adipose Tissue Inflammation", Cell Metab, 18, pp.759~766 (2013)
60. Wu D, "Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis", Science, 332, pp.243~247 (2011)
61. Yang H, "Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity : implications for systemic inflammation and insulin resistance", J Immunol, 185, pp.1836~1845 (2010)
62. Molofsky AB, "Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages", J Exp Med, 210, pp.535~549 (2013)
63. Wensveen FM, "NK cells link obesity-induced adipose stress to inflammation and insulin resistance", Nat Immunol, 16, pp.376~385 (2015)
64. Ridker PM, "Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease", N Engl J Med, 377, pp.1119~1131 (2017)
65. Ridker PM, "Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis : exploratory results from a randomised, double-blind, placebo-controlled trial", Lancet, 390, pp.1833~1842 (2017)
66. Everett BM, "Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes", J Am Coll Cardiol, 71, pp.2392~2401 (2018)
67. Hauser TH, "Effect of Targeting Inflammation With Salsalate : The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins", JAMA Cardiol, 1, pp.413~423 (2016)
68. Shi H, "TLR4 links innate immunity and fatty acid-induced insulin resistance", J Clin Invest, 116, pp.3015~3025 (2006)
69. Jia L, "Hepatocyte Toll-like receptor 4 regulates obesityinduced inflammation and insulin resistance", Nat Commun, 5, pp.3878~ (2014)
70. Hosoi T, "Myeloid differentiation factor 88(MyD88)-deficiency increases risk of diabetes in mice", PLoS One, 5, pp.e12537~ (2010)
71. Hesketh M, "Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing", Int J Mol Sci, 18, pp.1545~ (2017)

관련 논문AI추천